Showing results (11-20 of 47) with videos related to
Sort By:
Pageof 5
Journal of Clinical Microbiology|August 1, 1992
Use of HEp-2 cells for improved isolation and passage of Chlamydia pneumoniaeP M Roblin, W Dumornay, M R HammerschlagAntimicrobial Agents and Chemotherapy|September 1, 1989
In vitro susceptibilities of Chlamydia pneumoniae (Chlamydia sp. strain TWAR)K Chirgwin, P M Roblin, M R HammerschlagAntimicrobial Agents and Chemotherapy|September 26, 1997
In vitro activity of trovafloxacin against Chlamydia pneumoniaeP M Roblin, A Kutlin, M R HammerschlagAntimicrobial Agents and Chemotherapy|March 1, 1992
In vitro activities of five quinolones against Chlamydia pneumoniaeM R Hammerschlag, C L Hyman, P M RoblinJournal of Clinical Microbiology|May 1, 1994
Performance of three commercially available monoclonal reagents for confirmation of Chlamydia pneumoniae in cell cultureG S Montalban, P M Roblin, M R HammerschlagThe Journal of Antimicrobial Chemotherapy|September 22, 2001
Activity of telithromycin, a new ketolide antibacterial, against atypical and intracellular respiratory tract pathogensM R Hammerschlag, P M Roblin, C M BébéarAntimicrobial Agents and Chemotherapy|July 1, 1992
In vitro activities of azithromycin, clarithromycin, L-ofloxacin, and other antibiotics against Chlamydia pneumoniaeM R Hammerschlag, K K Qumei, P M RoblinJournal of Clinical Microbiology|June 1, 1990
Comparison of Kodak Surecell Chlamydia Test Kit with culture for the diagnosis of chlamydial conjunctivitis in infantsM R Hammerschlag, M Gelling, P M Roblin, et al.Antimicrobial Agents and Chemotherapy|March 18, 2000
In vitro activity of ABT 773, a new ketolide antibiotic, against Chlamydia pneumoniaeS Strigl, P M Roblin, T Reznik, et al.The Journal of Antimicrobial Chemotherapy|May 1, 1997
In-vitro activity of dirithromycin against Chlamydia pneumoniaeP M Roblin, A Kutlin, N Sokolovskaya, et al.Pageof 5